Study of TAK-901 in Adults With Advanced Solid Tumors or Lymphoma



Status:Archived
Conditions:Cancer, Lymphoma
Therapuetic Areas:Oncology
Healthy:No
Age Range:Any
Updated:7/1/2011
Start Date:October 2009
End Date:June 2012

Use our guide to learn which trials are right for you!

Trial Summary
Trial Overview
Inclusion Criteria

An Open-Label, Dose Escalation, Phase I Study of TAK-901 in Adult Patients With Advanced Solid Tumors or Lymphoma


This study is being conducted to evaluate the safety profile and the Maximum Tolerated Dose
(MTD) of TAK-901 in adult patients with advanced solid tumors or lymphoma. This study will
help to identify the recommended phase 2 dose and infusion duration, and describe the
pharmacokinetics of TAK-901.



We found this trial at
3
sites
University of Michigan Health Systems
1500 E Medical Center Dr
Ann Arbor, Michigan 48109
(734) 936-4000
University of Michigan Health Systems The University of Michigan is home to one of the...
?
mi
from
Ann Arbor, MI
Click here to add this to my saved trials
Karmanos Cancer Center
Detroit, Michigan 48202
?
mi
from
Detroit, MI
Click here to add this to my saved trials
Fox Chase Cancer Center
333 Cottman Ave
Philadephia, Pennsylvania 19111
(215) 728-6900
Fox Chase Cancer Center Fox Chase has earned the prestigious designation from the National Cancer...
?
mi
from
Philadephia, PA
Click here to add this to my saved trials